Will AI take away our sense of purpose? Sam Altman says, ‘People Will have to redefine what it means to contribute'
OpenAI
CEO Sam Altman sat down with podcaster Theo Von on This Past Weekend. What unfolded was less a traditional interview and more a deeply human dialogue about the hopes, fears, and massive unknowns surrounding artificial intelligence.
As AI continues its unstoppable advance, Von posed a question many of us have been quietly asking: 'Are we racing toward a future where humans no longer matter?'
Explore courses from Top Institutes in
Please select course:
Select a Course Category
Digital Marketing
Data Science
Data Analytics
Artificial Intelligence
others
Project Management
Leadership
Management
Operations Management
Technology
Product Management
Cybersecurity
CXO
Design Thinking
Public Policy
Others
Data Science
Finance
PGDM
Degree
Healthcare
MBA
MCA
healthcare
Skills you'll gain:
Digital Marketing Strategy
Search Engine Optimization (SEO) & Content Marketing
Social Media Marketing & Advertising
Data Analytics & Measurement
Duration:
24 Weeks
Indian School of Business
Professional Certificate Programme in Digital Marketing
Starts on
Jun 26, 2024
Get Details
Skills you'll gain:
Digital Marketing Strategies
Customer Journey Mapping
Paid Advertising Campaign Management
Emerging Technologies in Digital Marketing
Duration:
12 Weeks
Indian School of Business
Digital Marketing and Analytics
Starts on
May 14, 2024
Get Details
'We're Still the Main Characters'—But for How Long?
Altman didn't sugarcoat the situation. He agreed with many of Von's concerns, from data privacy to AI replacing jobs, and even the unnerving pace at which the technology is evolving.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Never Put Eggs In The Refrigerator. Here's Why...
Car Novels
Undo
'There's this race happening,' Altman said, referring to the breakneck competition among tech companies. 'If we don't move fast, someone else will — and they might not care as much about the consequences.'
But amid all the alarms, Altman offered a cautious dose of optimism. 'Even in a world where AI is doing all of this stuff humans used to do,' he said, 'we are going to find a way to feel like the main characters.' His tone, however, betrayed a sense of uncertainty: the script isn't written yet.
You Might Also Like:
Telling secrets to ChatGPT? Using it as a therapist? Your AI chats aren't legally private, warns Sam Altman
AI and the Crisis of Human Purpose
Perhaps the most powerful moment came when Von bluntly asked: 'What happens to our sense of purpose when AI does everything for us?'
Altman acknowledged that work has always been a major source of meaning for people. While he's hopeful that AI will free humans to pursue more creative or emotional pursuits, he conceded that the transition could be deeply painful.
'One of the big fears is like purpose, right?' Von said. 'Like, work gives us purpose. If AI really continues to advance, it feels like our sense of purpose would start to really disappear.'
Altman responded with guarded hope: 'People will have to redefine what contribution looks like… but yeah, it's going to be unsettling.'
You Might Also Like:
Sam Altman wishes to give 'free GPT-5' to everyone on Earth: OpenAI CEO's bold dream sparks awe and alarm
AI as Therapist? The Privacy Dilemma We Can't Ignore
In what may be one of the most revealing admissions from a tech CEO, Altman addressed the disturbing trend of people — especially young users — turning to AI as a confidant or therapist.
'People talk about the most personal sh*t in their lives to ChatGPT,' he told Von. 'But right now, if you talk to a therapist or a lawyer or a doctor about those problems, there's legal privilege… We haven't figured that out yet for when you talk to ChatGPT.'
With AI tools lacking legal confidentiality protections, users risk having their most intimate thoughts stored, accessed, or even subpoenaed in court. The privacy gap is real, and Altman admitted the industry is still trying to figure it out.
A Legal Gray Zone and a Growing Cloud of Concern
Adding to the complexity, Altman highlighted how the lack of federal AI regulations has created a patchwork of rules that vary wildly across states. This legal uncertainty is already playing out in real-time — OpenAI, for example, is currently required to retain user conversations, even deleted ones, as part of its legal dispute with The New York Times.
'No one had to think about that even a year ago,' Altman said, calling the situation 'very screwed up.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
27 minutes ago
- Time of India
Healthcare costs in US to shoot up following Trump tariff on Indian goods: Industry experts
New Delhi: Healthcare costs in the US will increase following the imposition of sweeping 25 per cent tariff plus an unspecified penalty on Indian goods, experts from pharmaceuticals and medical devices industry said on Thursday. President Donald Trump on Wednesday announced the imposition of a 25 per cent tariff on all goods coming from India starting August 1, plus an unspecified penalty for buying Russian crude oil and military equipment. Explore courses from Top Institutes in Please select course: Select a Course Category healthcare Project Management Finance Technology Operations Management Artificial Intelligence Data Science Management PGDM Data Science Product Management Degree Others Healthcare Public Policy Design Thinking Cybersecurity Digital Marketing others CXO Leadership MCA MBA Data Analytics Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML Healthcare Management India Starts on undefined Get Details Profits for Indian pharmaceutical firms may decline and research and development may stagnate. However, for the medical devices sector as long as the gap between duty on China and India is over 15- 20 per cent, there are positive prospects for exports to the US, according to experts. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Most Beautiful Women in the World Undo "India isn't just a key supplier of generics to the US. We are a part of the backbone of affordable global healthcare. These duties may interrupt the smooth trade flow, inflate US drug costs, stall treatments, and put even greater pressure on American healthcare budgets," OmniActive Health Technologies Executive Chairman and MD Sanjaya Mariwala said. On the other hand, he said, "Back home, the profits for Indian pharmaceutical firms may decline, and R&D may stagnate, slowing down innovation and stalling new drug clearances." Live Events AiMeD (Association of Indian Medical Device Industry) Forum Coordinator Rajiv Nath said, "Duties impact for Indian medical devices sector has to be seen from relative competitiveness - as long as duty gap between Chinese versus Indian is over 15- 20 per cent, we have positive prospects to export to USA and even put production lines in USA." Currently Indonesia and Vietnam have lower duties by 6 per cent. So for products made there they will possibly enjoy a price competitive advantage over India, he added. Stating that clarity will come after August 12 as then duties on Chinese goods will be clear, Nath said, "They were increased to over 50 per cent but temporarily reduced to 30 per cent. If post-August duties on Chinese medical devices revert to over 50 per cent and on Indian at 25 per cent, the export prospects versus China are in our favour..." He further said, "Suffice to say that whatever is the final duty that is finally announced on medical devices, if it's at least 15-20 per cent lower than applicable duty rates by US onto China then there is a strong opportunity for Indian medical devices to increase their exports to US market, if they are able to absorb the excessive high cost of regulatory approval of USFDA for market entry and find that these costs to export are sustainable over the years." However, he said, the government of India and manufacturers will need to work to improve India's competitiveness "so that we can offset the 6 per cent disadvantage over Indonesian and Vietnam competitors". Grant Thornton Bharat Partner and Tax Controversy Management Leader Manoj Mishra pointed out that the strong language used by President Trump and ongoing investigations into drug imports mean that the risk is not over yet. "Indian pharma companies should stay prepared for possible changes, especially if sector-specific duties are introduced later. That said, these tariffs are likely to be in place only for a short period, as both countries are expected to fast-track discussions for a Bilateral Trade Agreement. A balanced and stable trade deal will be key to protecting long-term interests of the sector," he noted. Similarly, Choice Broking Equity Research Analyst- Pharma Sector, Maitri Sheth said the US remains heavily reliant on India for its pharmaceutical needs, with about 50 per cent of generic drugs sourced from India. "Given the critical nature of healthcare and already elevated healthcare costs in the US, we view the likelihood of material near-term tariffs on pharma as low," Sheth added. While the headline risk persists, the structural dependence on Indian pharma and the cost sensitivity of the US healthcare system provide a strong case against aggressive tariff action on the sector, Sheth added. Medical Technology Association of India (MTaI) Chairman Pavan Choudary said President Trump's is "troubling and seems economically shortsighted and strategically misguided".
Time of India
27 minutes ago
- Time of India
US mortgage rate shift: 30-year home loan eases to 6.72% after Fed decision; housing demand stays weak
The average rate on a 30-year fixed US mortgage slipped to 6.72% this week, down slightly from 6.74% a week earlier and matching levels last seen three weeks ago, mortgage buyer Freddie Mac said on Thursday. The minor decline offers limited relief for buyers grappling with high home prices and borrowing costs. A year ago, the 30-year rate was 6.73%. The average rate for a 15-year fixed mortgage, often used for refinancing, also fell to 5.85% from 5.87%. These marginal rate changes come as the US housing market remains mired in a prolonged sales slump, dating back to 2022, when mortgage rates began rising from pandemic-era lows. Mortgage rates are primarily guided by the 10-year Treasury yield, which fell to 4.34% on Thursday from 4.37% the previous day. Bond yields have been elevated for most of July, as markets anticipated the Federal Reserve would hold rates steady, which it confirmed on Wednesday. Fed Chair Jerome Powell also dismissed hopes for a rate cut in September, citing persistent inflation and a still-balanced job market. 'A September rate cut could push mortgage rates lower at summer's end, as we saw last year,' said Lisa Sturtevant, chief economist at Bright MLS. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Acton - This Trusted Tool is Helping Drivers Quickly Compare Auto Insurance Rates Policy Auto Pro Get Quote Undo 'But if inflation expectations stay elevated, rates could remain stuck above 6%.' The 30-year mortgage rate peaked above 7% in mid-January and briefly dipped to 6.62% in April. Forecasts from and Fannie Mae suggest it may ease to around 6.4% by year-end, still too high to reverse the downturn in housing activity. Pending home sales data point to more weakness ahead. The National Association of Realtors reported a 0.8% decline in June contract signings from May, and a 2.8% drop from a year earlier. The homeownership rate, meanwhile, remains stagnant at 65%—its lowest since 2019. Mortgage applications also declined 3.8% last week to their lowest level since May, despite the recent rate dip. 'There is still plenty of uncertainty surrounding the economy and job market, which is weighing on prospective homebuyers' decisions,' said Joel Kan, deputy chief economist at the Mortgage Bankers Association. Stay informed with the latest business news, updates on bank holidays and public holidays . Discover stories of India's leading eco-innovators at Ecopreneur Honours 2025
Time of India
27 minutes ago
- Time of India
PM Modi to transfer Rs 20,500 crore to accounts of over 9.7 crore farmers in Varanasi on August 2
VARANASI: Prime Minister Narendra Modi is set to deliver a significant gift to farmers across the nation ahead of Raksha Bandhan, a release said. During his visit to Varanasi on August 2, PM Modi will release the 20th instalment of the PM Kisan Samman Nidhi scheme, transferring over Rs 20,500 crore directly into the accounts of 9.7 crore eligible farmers. Uttar Pradesh alone will see more than 2.3 crore farmers receive Rs 4,600 crore, including Rs 48 crore to 2.21 lakh farmers in Varanasi. Under the PM Kisan Samman Nidhi scheme, all eligible farmers receive equal instalments of annual assistance. Every landholding farmer family gets Rs 6,000 per year, given in three equal instalments of Rs 2,000 each, as per the release by the Uttar Pradesh government. On August 2, Prime Minister Narendra Modi will address a public meeting at Banouli village in the Sevapuri block of Varanasi. From the event venue, he will inaugurate and lay the foundation stone for 52 development projects worth Rs 2,183.45 crore. The Prime Minister is scheduled to arrive at Lal Bahadur Shastri International Airport around 10:30 am, where he will be received by chief minister Yogi Adityanath and other public representatives. Prime Minister Narendra Modi will lay the foundation stone and inaugurate multiple development projects worth around Rs 2,200 crore in Varanasi, Uttar Pradesh, on August 2 at around 11 am. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Your New Zealand escape starts with Singapore Airlines Fly with Singapore Airlines Book Now Undo The projects cater to multiple sectors, including infrastructure, education, healthcare, tourism, urban development, and cultural heritage, aim at achieving holistic urban transformation, cultural rejuvenation, improved connectivity, and enhanced quality of life in Varanasi. In line with his commitment to improve road connectivity in Varanasi, the Prime Minister will inaugurate and lay the foundation stone of several key infrastructure projects. He will inaugurate the widening and strengthening of the Varanasi - Bhadohi road and Chhitauni- Shool Tankeshwar road, and the Railway Overbridge at Hardattpur, to ease congestion on the Mohan Sarai - Adalpura Road. In line with his commitment to improve road connectivity in Varanasi, the Prime Minister will inaugurate and lay the foundation stone of several key infrastructure projects. He will inaugurate the widening and strengthening of the Varanasi - Bhadohi road and Chhitauni- Shool Tankeshwar road, and the Railway Overbridge at Hardattpur, to ease congestion on the Mohan Sarai - Adalpura Road.
